Literature DB >> 23349207

The low-resolution structure of nHDL reconstituted with DMPC with and without cholesterol reveals a mechanism for particle expansion.

Valentin Gogonea1, Gary S Gerstenecker, Zhiping Wu, Xavier Lee, Celalettin Topbas, Matthew A Wagner, Thomas C Tallant, Jonathan D Smith, Philip Callow, Vitaliy Pipich, Hélène Malet, Guy Schoehn, Joseph A DiDonato, Stanley L Hazen.   

Abstract

Small-angle neutron scattering (SANS) with contrast variation was used to obtain the low-resolution structure of nascent HDL (nHDL) reconstituted with dimyristoyl phosphatidylcholine (DMPC) in the absence and presence of cholesterol, [apoA1:DMPC (1:80, mol:mol) and apoA1:DMPC:cholesterol (1:86:9, mol:mol:mol)]. The overall shape of both particles is discoidal with the low-resolution structure of apoA1 visualized as an open, contorted, and out of plane conformation with three arms in nascent HDL/dimyristoyl phosphatidylcholine without cholesterol (nHDL(DMPC)) and two arms in nascent HDL/dimyristoyl phosphatidylcholine with cholesterol (nHDL(DMPC+Chol)). The low-resolution shape of the lipid phase in both nHDL(DMPC) and nHDL(DMPC+Chol) were oblate ellipsoids, and fit well within their respective protein shapes. Modeling studies indicate that apoA1 is folded onto itself in nHDL(DMPC), making a large hairpin, which was also confirmed independently by both cross-linking mass spectrometry and hydrogen-deuterium exchange (HDX) mass spectrometry analyses. In nHDL(DMPC+Chol), the lipid was expanded and no hairpin was visible. Importantly, despite the overall discoidal shape of the whole particle in both nHDL(DMPC) and nHDL(DMPC+Chol), an open conformation (i.e., not a closed belt) of apoA1 is observed. Collectively, these data show that full length apoA1 retains an open architecture that is dictated by its lipid cargo. The lipid is likely predominantly organized as a bilayer with a micelle domain between the open apoA1 arms. The apoA1 configuration observed suggests a mechanism for accommodating changing lipid cargo by quantized expansion of hairpin structures.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23349207      PMCID: PMC3606002          DOI: 10.1194/jlr.M032763

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  54 in total

Review 1.  Interfacial enzyme kinetics at the phospholipid/water interface: practical considerations.

Authors:  R A Deems
Journal:  Anal Biochem       Date:  2000-12-01       Impact factor: 3.365

2.  Rotational and hinge dynamics of discoidal high density lipoproteins probed by interchain disulfide bond formation.

Authors:  Ling Li; Songlin Li; Martin K Jones; Jere P Segrest
Journal:  Biochim Biophys Acta       Date:  2011-10-19

3.  Three arginine residues in apolipoprotein A-I are critical for activation of lecithin:cholesterol acyltransferase.

Authors:  S Roosbeek; B Vanloo; N Duverger; H Caster; J Breyne; I De Beun; H Patel; J Vandekerckhove; C Shoulders; M Rosseneu; F Peelman
Journal:  J Lipid Res       Date:  2001-01       Impact factor: 5.922

4.  Apolipoprotein A-I assumes a "looped belt" conformation on reconstituted high density lipoprotein.

Authors:  Dale D O Martin; Madhu S Budamagunta; Robert O Ryan; John C Voss; Michael N Oda
Journal:  J Biol Chem       Date:  2006-05-11       Impact factor: 5.157

5.  Intermolecular contact between globular N-terminal fold and C-terminal domain of ApoA-I stabilizes its lipid-bound conformation: studies employing chemical cross-linking and mass spectrometry.

Authors:  Shaila Bhat; Mary G Sorci-Thomas; Eric T Alexander; Michael P Samuel; Michael J Thomas
Journal:  J Biol Chem       Date:  2005-06-22       Impact factor: 5.157

6.  Crystal structure of truncated human apolipoprotein A-I suggests a lipid-bound conformation.

Authors:  D W Borhani; D P Rogers; J A Engler; C G Brouillette
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-11       Impact factor: 11.205

7.  Phospholipid composition of reconstituted high density lipoproteins influences their ability to inhibit endothelial cell adhesion molecule expression.

Authors:  P W Baker; K A Rye; J R Gamble; M A Vadas; P J Barter
Journal:  J Lipid Res       Date:  2000-08       Impact factor: 5.922

8.  Large disk intermediate precedes formation of apolipoprotein A-I-dimyristoylphosphatidylcholine small disks.

Authors:  Keng Zhu; Gregory Brubaker; Jonathan D Smith
Journal:  Biochemistry       Date:  2007-05-03       Impact factor: 3.162

9.  Heteronuclear NMR studies of human serum apolipoprotein A-I. Part I. Secondary structure in lipid-mimetic solution.

Authors:  Mark Okon; Philippe G Frank; Yves L Marcel; Robert J Cushley
Journal:  FEBS Lett       Date:  2002-04-24       Impact factor: 4.124

View more
  11 in total

1.  Kinetics of lipid mixing between bicelles and nanolipoprotein particles.

Authors:  Ginny Lai; Kevin Muñoz Forti; Robert Renthal
Journal:  Biophys Chem       Date:  2015-01-23       Impact factor: 2.352

2.  Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex.

Authors:  Ying Huang; Zhiping Wu; Meliana Riwanto; Shengqiang Gao; Bruce S Levison; Xiaodong Gu; Xiaoming Fu; Matthew A Wagner; Christian Besler; Gary Gerstenecker; Renliang Zhang; Xin-Min Li; Anthony J DiDonato; Valentin Gogonea; W H Wilson Tang; Jonathan D Smith; Edward F Plow; Paul L Fox; Diana M Shih; Aldons J Lusis; Edward A Fisher; Joseph A DiDonato; Ulf Landmesser; Stanley L Hazen
Journal:  J Clin Invest       Date:  2013-08-01       Impact factor: 14.808

3.  Small-angle X-ray scattering of the cholesterol incorporation into human ApoA1-POPC discoidal particles.

Authors:  Søren Roi Midtgaard; Martin Cramer Pedersen; Lise Arleth
Journal:  Biophys J       Date:  2015-07-21       Impact factor: 4.033

4.  A Systematic Investigation of Structure/Function Requirements for the Apolipoprotein A-I/Lecithin Cholesterol Acyltransferase Interaction Loop of High-density Lipoprotein.

Authors:  Xiaodong Gu; Zhiping Wu; Ying Huang; Matthew A Wagner; Camelia Baleanu-Gogonea; Ryan A Mehl; Jennifer A Buffa; Anthony J DiDonato; Leah B Hazen; Paul L Fox; Valentin Gogonea; John S Parks; Joseph A DiDonato; Stanley L Hazen
Journal:  J Biol Chem       Date:  2016-01-21       Impact factor: 5.157

Review 5.  Molecules that mimic apolipoprotein A-I: potential agents for treating atherosclerosis.

Authors:  Luke J Leman; Bruce E Maryanoff; M Reza Ghadiri
Journal:  J Med Chem       Date:  2013-10-29       Impact factor: 7.446

Review 6.  Applications of hydrogen/deuterium exchange MS from 2012 to 2014.

Authors:  Gregory F Pirrone; Roxana E Iacob; John R Engen
Journal:  Anal Chem       Date:  2014-11-14       Impact factor: 6.986

7.  Comparison of apoA-I helical structure and stability in discoidal and spherical HDL particles by HX and mass spectrometry.

Authors:  Palaniappan Sevugan Chetty; David Nguyen; Margaret Nickel; Sissel Lund-Katz; Leland Mayne; S Walter Englander; Michael C Phillips
Journal:  J Lipid Res       Date:  2013-04-10       Impact factor: 5.922

8.  An abundant dysfunctional apolipoprotein A1 in human atheroma.

Authors:  Ying Huang; Joseph A DiDonato; Bruce S Levison; Dave Schmitt; Lin Li; Yuping Wu; Jennifer Buffa; Timothy Kim; Gary S Gerstenecker; Xiaodong Gu; Chandra S Kadiyala; Zeneng Wang; Miranda K Culley; Jennie E Hazen; Anthony J Didonato; Xiaoming Fu; Stela Z Berisha; Daoquan Peng; Truc T Nguyen; Shaohong Liang; Chia-Chi Chuang; Leslie Cho; Edward F Plow; Paul L Fox; Valentin Gogonea; W H Wilson Tang; John S Parks; Edward A Fisher; Jonathan D Smith; Stanley L Hazen
Journal:  Nat Med       Date:  2014-01-26       Impact factor: 53.440

9.  Microenvironmentally controlled secondary structure motifs of apolipoprotein A-I derived peptides.

Authors:  Paola Mendoza-Espinosa; Danai Montalvan-Sorrosa; Victor García-González; Abel Moreno; Rolando Castillo; Jaime Mas-Oliva
Journal:  Mol Cell Biochem       Date:  2014-04-20       Impact factor: 3.396

Review 10.  Structural Insights into High Density Lipoprotein: Old Models and New Facts.

Authors:  Valentin Gogonea
Journal:  Front Pharmacol       Date:  2016-01-12       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.